Shares of Eden Research plc (LON:EDEN – Get Free Report) were up 2.8% on Wednesday following insider buying activity. The stock traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). Approximately 12,234,783 shares changed hands during mid-day trading, an increase of 664% from the average daily volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey purchased 540,540 shares of Eden Research stock in a transaction on Tuesday, January 28th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($26,902.58).
Eden Research Stock Performance
The firm’s 50-day moving average price is GBX 3.88 and its 200 day moving average price is GBX 4.01. The company has a market cap of £19.73 million, a price-to-earnings ratio of -200.00 and a beta of 0.92. The company has a debt-to-equity ratio of 1.25, a quick ratio of 2.42 and a current ratio of 3.80.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Featured Articles
- Five stocks we like better than Eden Research
- Ride Out The Recession With These Dividend Kings
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is a support level?
- What Does the Future Hold for Eli Lilly?
- Top Biotech Stocks: Exploring Innovation Opportunities
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
